PT Kalbe Farma Tbk.
Bear Case (25th pct.)
37.4% vs price
Base Case (Median)
53.8% vs price
Bull Case (75th pct.)
102.7% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $329.11 | -55.5% | High (40%) |
| PE Comparable | $1765.52 | 138.6% | Medium (25%) |
| Growth Trajectory DCF | $1235.07 | 66.9% | Medium (20%) |
| Graham Number | $958.40 | 29.5% | Medium (40%) |
| EV/EBITDA | $1137.78 | 53.8% | Medium (20%) |
| EV/FCF | $1075.07 | 45.3% | Medium (20%) |
| Earnings Power Value | $2005.11 | 171.0% | Medium (50%) |
Based on 7 out of 8 methods, KLBF.JK appears undervalued at the current price of $740.00. The base case fair value of $1137.78 implies 53.8% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.